---
title: "Cimetidine - Systemic mast cell disease"
sidebar: mydoc_sidebar
permalink: db00501-mesh-d034721-1.html
toc: false 
---


Path ID: `DB00501_MESH_D034721_1`
{% include image.html url="images/db00501-mesh-d034721-1.png" file="db00501-mesh-d034721-1.png" alt="db00501-mesh-d034721-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002927 | Cimetidine | Drug |
| UniProt:P25021 | Histamine H2 receptor | Protein |
| GO:0001821 | Histamine secretion | BiologicalProcess |
| CL:0000097 | Mast cell | Cell |
| MESH:D034721 | Systemic mast cell disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cimetidine | DECREASES ACTIVITY OF | Histamine H2 Receptor |
| Histamine H2 Receptor | PREVENTS | Histamine Secretion |
| Histamine Secretion | LOCATED IN | Mast Cell |
| Mast Cell | CORRELATED WITH | Systemic Mast Cell Disease |
|---------|-----------|---------|

Comment: Cimetidine has a role in treating the symptoms of systemic mastocytosis

Reference: 
  - [https://go.drugbank.com/drugs/DB00501#mechanismofaction](https://go.drugbank.com/drugs/DB00501#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology](https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology)
